In CESC patients, FDX1 was involved in the downstream signaling of activated FGFR4, diseases of metabolism, and SHC-mediated cascade FGFR4 (Supplementary Fig. 11C). This evidence concerns the gene SHC1 and cervical squamous cell carcinoma.